Bio Green Med Solution (BGMS) Net Cash Flow Growth (3y) (2013 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Net Cash Flow Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | -8.34% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 36.60% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | -35.85% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 106.37% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 67.39% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 4.55% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 52.78% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 32.20% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 32.20% |
| Mar 31, 2026 | 70.70% |
| Dec 31, 2025 | 61.53% |
| Sep 30, 2025 | 56.84% |
| Jun 30, 2025 | 56.81% |
| Mar 31, 2025 | 27.21% |
| Dec 31, 2024 | 27.45% |
| Sep 30, 2024 | 2.55% |
| Jun 30, 2024 | 40.31% |
| Mar 31, 2024 | -26.81% |
| Dec 31, 2023 | -31.75% |
| Sep 30, 2023 | -22.39% |
| Jun 30, 2023 | -27.70% |
| Mar 31, 2023 | -34.21% |
| Dec 31, 2022 | -64.06% |
| Sep 30, 2022 | -37.92% |
| Jun 30, 2022 | 45.46% |
| Mar 31, 2022 | -167.38% |
| Dec 31, 2021 | -35.83% |
| Sep 30, 2021 | -62.33% |